Tatsuno I - Search Results

1

Incidence of symptomatic vertebral fractures in women of childbearing age newly treated with high-dose glucocorticoid.

Sugiyama T, Suzuki S, Yoshida T, Suyama K, Tanaka T, Sueishi M, Tatsuno I. Sugiyama T, et al. Among authors: tatsuno i. Gend Med. 2010 Jun;7(3):218-29. doi: 10.1016/j.genm.2010.06.004. Gend Med. 2010. PMID: 20638627

2

Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases.

Tatsuno I, Sugiyama T, Suzuki S, Yoshida T, Tanaka T, Sueishi M, Saito Y. Tatsuno I, et al. J Clin Endocrinol Metab. 2009 May;94(5):1671-7. doi: 10.1210/jc.2008-1578. Epub 2009 Mar 3. J Clin Endocrinol Metab. 2009. PMID: 19258412

3

Incidence of symptomatic vertebral fracture with high-dose glucocorticoid treatment in the Chiba-Shimoshizu Rheumatic Cohort between 1986 and 2006.

Sugiyama T, Tatsuno I, Suzuki S, Yoshida T, Tanaka T, Sueishi M, Saito Y. Sugiyama T, et al. Among authors: tatsuno i. Endocr J. 2009;56(4):591-9. doi: 10.1507/endocrj.k08e-318. Epub 2009 Apr 7. Endocr J. 2009. PMID: 19352047 Free article.

4

Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment.

Tatsuno I, Sugiyama T. Tatsuno I, et al. Diabetes Res Clin Pract. 2011 Jul;93(1):e18-20. doi: 10.1016/j.diabres.2011.03.005. Epub 2011 Mar 26. Diabetes Res Clin Pract. 2011. PMID: 21440321

5

Age, initial dose and dose increase are independent risk factors for symptomatic vertebral fractures in glucocorticoid-treated male patients.

Sugiyama T, Suzuki S, Yoshida T, Mayama T, Hashimoto N, Suyama K, Tanaka T, Sueishi M, Tatsuno I. Sugiyama T, et al. Among authors: tatsuno i. Intern Med. 2011;50(8):817-24. doi: 10.2169/internalmedicine.50.4443. Epub 2011 Apr 15. Intern Med. 2011. PMID: 21498928 Free article.

6

High prevalence and early complication of symptomatic vertebral fracture in elderly people treated with high-dose glucocorticoids.

Tatsuno I, Suzuki S, Yoshida T, Tanaka T, Sueishi M, Sugiyama T. Tatsuno I, et al. J Am Geriatr Soc. 2009 Jan;57(1):188-9. doi: 10.1111/j.1532-5415.2009.02077.x. J Am Geriatr Soc. 2009. PMID: 19170810 No abstract available.

7

Vasopressin responders have a high prevalence of hypertension and insulin resistance in spite of a lower secretion of cortisol in subclinical Cushing's syndrome.

Suzuki S, Uchida D, Koide H, Suyama K, Tanaka T, Noguchi Y, Saito Y, Tatsuno I. Suzuki S, et al. Among authors: tatsuno i. Mol Med Rep. 2009 Jan-Feb;2(1):115-20. doi: 10.3892/mmr_00000071. Mol Med Rep. 2009. PMID: 21475800

8

Current smoking is an independent risk factor for new-onset diabetes mellitus during highdose glucocorticoid treatment.

Sugiyama T, Sugimoto T, Suzuki S, Sato Y, Tanaka T, Tatsuno I. Sugiyama T, et al. Among authors: tatsuno i. Int J Clin Pharmacol Ther. 2015 Aug;53(8):616-20. doi: 10.5414/CP202136. Int J Clin Pharmacol Ther. 2015. PMID: 25997545

9

Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.

Oka R, Ohira M, Suzuki S, Yoshida T, Koide H, Tanaka T, Tatsuno I. Oka R, et al. Among authors: tatsuno i. Endocr J. 2018 Feb 26;65(2):193-202. doi: 10.1507/endocrj.EJ17-0331. Epub 2017 Nov 18. Endocr J. 2018. PMID: 29151451 Free article.

10

Fracture Risk Assessment Tool May Not Indicate Bone Fragility in Women With Type 2 Diabetes.

Ohira M, Suzuki S, Yoshida T, Koide H, Tanaka T, Tatsuno I. Ohira M, et al. Among authors: tatsuno i. Am J Med Sci. 2020 Nov;360(5):552-559. doi: 10.1016/j.amjms.2020.04.002. Epub 2020 Apr 11. Am J Med Sci. 2020. PMID: 32376002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

316 results

Search Page

Filters